Argent Biopharma Limited has released a press release.
Shareholder Priority Offer Closed Early - Oversubscribed
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Prospectus - Priority Offer
- Priority Offer Timetable - Update
- Supplementary Prospectus
- European Commission Approves MGC Derma Cosmetics Products
- ASX Approval of Panax Transaction and Capital Raising Update
Later from Argent Biopharma
- FDA Approval Granted and First US Distribution Deal Signed
- Health Canada Approves MGC Derma CBD Cosmetics
- MXCs First Crops Planted at European CBD Production Farm
- First Revenues Received from Californian Cosmetics Deal
- Leading Epilepsy Expert Joins MXC Strategic Advisory Board
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma